Compare GGB & CAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GGB | CAI |
|---|---|---|
| Founded | 1901 | 2008 |
| Country | Brazil | United States |
| Employees | N/A | N/A |
| Industry | Steel/Iron Ore | Medical Specialities |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.8B | 9.7B |
| IPO Year | 2000 | 2025 |
| Metric | GGB | CAI |
|---|---|---|
| Price | $4.39 | $25.06 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 5 | 14 |
| Target Price | $5.68 | ★ $32.46 |
| AVG Volume (30 Days) | ★ 17.6M | 3.3M |
| Earning Date | 10-26-2026 | 11-04-2026 |
| Dividend Yield | ★ 3.11% | N/A |
| EPS Growth | N/A | ★ 69.79 |
| EPS | N/A | ★ 0.05 |
| Revenue | N/A | ★ $812,033,000.00 |
| Revenue This Year | $2.52 | $26.84 |
| Revenue Next Year | $3.89 | $19.27 |
| P/E Ratio | ★ $13.89 | $664.40 |
| Revenue Growth | N/A | ★ 96.97 |
| 52 Week Low | $3.14 | $14.19 |
| 52 Week High | $5.48 | $36.50 |
| Indicator | GGB | CAI |
|---|---|---|
| Relative Strength Index (RSI) | 34.58 | 34.45 |
| Support Level | $4.05 | $16.52 |
| Resistance Level | $4.91 | $28.32 |
| Average True Range (ATR) | 0.20 | 2.00 |
| MACD | -0.06 | -0.92 |
| Stochastic Oscillator | 5.67 | 8.02 |
Gerdau SA produces steel and steel products. The company operates in civil construction, agriculture, automotive, iron ore, exports, research and development, and home steel products sectors. It offers products such as Semi-finished products (Billets, Blooms and Slabs), Special bar quality, Common Long Rolled Products, Dawn products, Merchant bar, Beams, Rebar, Piling, Iron Ore and Others. The company's geographical segment includes Brazil Segment; North America Segment; and South America Segment. It derives the majority of its revenue from the Brazil Operations segment, which includes the long, flat and special steel operations and the iron ore operation located in Brazil and joint ventures and associated companies located in Brazil.
Caris Life Sciences Inc is a patient-centric, next-generation AI TechBio company. It develop and commercialize solutions to transform healthcare through the use of comprehensive molecular information and artificial intelligence/machine learning algorithms at scale.